Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.
Suppression of endogenous glucose production (EGP) is one of insulin's primary metabolic effects and failure of this action is a major contributor to fasting hyperglycemia of type 2 diabetes mellitus. Classically, insulin was thought to suppress the liver directly, via hyperinsulinemia in the portal...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
1997
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9399959/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119867 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
